retatrutide kuwait ("Reta") Is Trending on Social Media. But Is It Safe? Eli Lilly's retatrutide sets new
Description
Retatrutide is an investigational triple hormone receptor agonist that simultaneously targets glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Every needle-averse patient, every emerging-market pharmacy without cold-chain distribution, every employer benefits manager choking on injectable pricing suddenly becomes addressable
Without insurance, the cost of both medications range between $650 and $1,500 for a 28 day supply
PMID: 29617641
Just smart, science-backed care tailored to your life
Shared decision-making becomes especially important when patients are experiencing meaningful improvements in glycemic control or weight reduction
